Dicot Pharma Ab Is A Pharmaceutical Company Located In Uppsalaswedenestablished In 2015The Company Focuses On Developing Innovative Treatments For Erectile Dysfunction And Premature Ejaculationits Primary Product In Development Is Lib 01A Drug Candidate Currently In Phase 2 Clinical Trialswhich Aims To Offer Improved Treatment Options Compared To Existing Medicationsdicot Pharma Collaborates With Leading Partners And Experts Globally To Advance Its Clinical Research The Company Has A Strong Intellectual Property Strategyholding Seven Patent Families With Granted Patents Extending Until 2042Including Approvals In The U Smarketdicot Pharma Is Listed On The Nasdaq Stockholm Exchange Under The Ticker Symbol Dicotthe Leadership Team Includes Ceo Elin Trampe And Cfo Bjorn Peterssonsupported By An Independent Boarddicot Pharma Is Dedicated To Addressing A Significant Global Health Issueaiming To Create Treatments That Provide Longer Durationfewer Side Effectsand Broader Effectiveness
